A new cyclophilin inhibitor from Ganoderma lucidum: Purification and characterization

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

A new inhibitor for peptidylprolyl cis-trans isomerase (PPIase) has been isolated from Ganoderma lucidum and purified to homogeneous state by organic solvent extraction. The purified PPIase inhibitor (GPI) is assumed to be a membrane-associated glycoprotein. GPI inhibits specifically the bovine brain PPIase, a cyclophilin, and has no effect on the FKBP activity. The results of our chemical modification study of GPI indicate the presence of Lys residue(s) at or near its binding site. Like CsA-cyclophilin complex, GPI-bovine brain PPIase complex strongly inhibits the calcineurin activity in vitro, suggesting the possible involvement of GPI in immunomodulating pathway by the formation of PPIase-inhibitor-calcineurin complex.

Cite

CITATION STYLE

APA

Jin, I. L., Ki, C. J., Kang, I. S., & Kim, S. J. (2004). A new cyclophilin inhibitor from Ganoderma lucidum: Purification and characterization. Bulletin of the Korean Chemical Society, 25(7), 1055–1060. https://doi.org/10.5012/bkcs.2004.25.7.1055

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free